- Letter
- Published:
Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1
- Christopher I Amos1,
- Xifeng Wu1,
- Peter Broderick2,
- Ivan P Gorlov1,
- Jian Gu1,
- Timothy Eisen3,
- Qiong Dong1,
- Qing Zhang1,
- Xiangjun Gu1,
- Jayaram Vijayakrishnan2,
- Kate Sullivan2,
- Athena Matakidou2,
- Yufei Wang2,
- Gordon Mills4,
- Kimberly Doheny5,
- Ya-Yu Tsai5,
- Wei Vivien Chen1,
- Sanjay Shete1,
- Margaret R Spitz1 na1 &
- …
- Richard S Houlston2 na1
Nature Geneticsvolume 40, pages616–622 (2008)Cite this article
4562Accesses
996Citations
51Altmetric
Abstract
To identify risk variants for lung cancer, we conducted a multistage genome-wide association study. In the discovery phase, we analyzed 315,450 tagging SNPs in 1,154 current and former (ever) smoking cases of European ancestry and 1,137 frequency-matched, ever-smoking controls from Houston, Texas. For replication, we evaluated the ten SNPs most significantly associated with lung cancer in an additional 711 cases and 632 controls from Texas and 2,013 cases and 3,062 controls from the UK. Two SNPs, rs1051730 and rs8034191, mapping to a region of strong linkage disequilibrium within 15q25.1 containingPSMA4 and the nicotinic acetylcholine receptor subunit genesCHRNA3 andCHRNA5, were significantly associated with risk in both replication sets. Combined analysis yielded odds ratios of 1.32 (P < 1 × 10−17) for both SNPs. Haplotype analysis was consistent with there being a single risk variant in this region. We conclude that variation in a region of 15q25.1 containing nicotinic acetylcholine receptors genes contributes to lung cancer risk.
This is a preview of subscription content,access via your institution
Access options
Subscription info for Japanese customers
We have a dedicated website for our Japanese customers. Please go tonatureasia.com to subscribe to this journal.
Prices may be subject to local taxes which are calculated during checkout



Similar content being viewed by others

Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population
References
Tokuhata, G.K. & Lilienfeld, A.M. Familial aggregation of lung cancer in humans.J. Natl. Cancer Inst.30, 289–312 (1963).
Amos, C.I., Xu, W. & Spitz, M.R. Is there a genetic basis for lung cancer susceptibility?Recent Results Cancer Res.151, 3–12 (1999).
Jonsson, S. et al. Familial risk of lung carcinoma in the Icelandic population.J. Am. Med. Assn.22, 2977–2983 (2004).
Hwang, S.J. et al. Lung cancer risk in germline p53 mutation carriers: association between an inherited cancer predisposition, cigarette smoking, and cancer risk.Hum. Genet.113, 238–243 (2003).
Sanders, B.M., Jay, M., Draper, G.J. & Roberts, E.M. Non-ocular cancer in relatives of retinoblastoma patients.Br. J. Cancer60, 358–365 (1989).
Kleinerman, R.A. et al. Hereditary retinoblastoma and risk of lung cancer.J. Natl. Cancer Inst.92, 2037–2039 (2000).
Takemiya, M., Shiraishi, S., Teramoto, T. & Miki, Y. Bloom's syndrome with porokeratosis of Mibelli and multiple cancers of the skin, lung and colon.Clin. Genet.31, 35–44 (1987).
Yamanaka, A., Hirai, T., Ohtake, Y. & Kitagawa, M. Lung cancer associated with Werner's syndrome: a case report and review of the literature.Jpn. J. Clin. Oncol.27, 415–418 (1997).
Bailey-Wilson, J.E. et al. A major lung cancer susceptibility locus maps to chromosome 6q23-25.Am. J. Hum. Genet.75, 460–474 (2004).
Webb, E.L. et al. Search for low penetrance alleles for colorectal cancer through a scan of 1467 non-synonymous SNPs in 2575 cases and 2707 controls with validation by kin-cohort analysis of 14,704 first-degree relatives.Hum. Mol. Genet.15, 3263–3271 (2006).
Zhang, Q. et al. Nicotine induces hypoxia-inducible factor-1alpha expression in human lung cancer cells via nicotinic acetylcholine receptor-mediated signaling pathways.Clin. Cancer Res.13, 4686–4694 (2007).
Lam, D.C. et al. Expression of nicotinic acetylcholine receptor subunit genes in non-small-cell lung cancer reveals differences between smokers and nonsmokers.Cancer Res.67, 4638–4647 (2007).
Minna, J.D. Nicotine exposure and bronchial epithelial cell nicotinic acetylcholine receptor expression in the pathogenesis of lung cancer.J. Clin. Invest.111, 31–33 (2003).
Trombino, S. et al. Alpha7-nicotinic acetylcholine receptors affect growth regulation of human mesothelioma cells: role of mitogen-activated protein kinase pathway.Cancer Res.64, 135–145 (2004).
Ho, Y.S. et al. Tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induces cell proliferation in normal human bronchial epithelial cells through NFkappaB activation and cyclin D1 up-regulation.Toxicol. Appl. Pharmacol.205, 133–148 (2005).
Saccone, S.F. et al. Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs.Hum. Mol. Genet.16, 36–49 (2007).
Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses.Am. J. Hum. Genet.81, 559–575 (2007).
Balding, D.J. A tutorial on statistical methods for population association studies.Nat. Rev. Genet.7, 781–791 (2006).
Devlin, B., Roeder, K. & Wasserman, L. Genomic control, a new approach to genetic-based association studies.Theor. Popul. Biol.60, 155–166 (2001).
Price, A.L. et al. Principal components analysis corrects for stratification in genome-wide association studies.Nat. Genet.38, 904–909 (2006).
Barrett, J.C., Fry, B., Maller, J. & Daly, M.J. Haploview: analysis and visualization of LD and haplotype maps.Bioinformatics21, 263–265 (2005).
de Bakker, P.I. et al. Efficiency and power in genetic association studies.Nat. Genet.37, 1217–1223 (2005).
Skol, A.D., Scott, L.J., Abecasis, G.R. & Boehnke, M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies.Nat. Genet.38, 209–213 (2006).
Acknowledgements
Partial support for this study has been provided by US National Institutes of Health grants R01CA133996, R01CA55769, P50 CA70907 and R01CA121197, the Kleberg Center for Molecular Markers at M.D. Anderson Cancer Center, and by support from the Flight Attendants Medical Research Institute. Genotyping services were provided by the Center for Inherited Disease Research (CIDR). CIDR is fully funded through a federal contract from the National Institutes of Health to The Johns Hopkins University, Contract Number N01-HG-65403. We thank the Kelsey Research Foundation for facilitating control selection in Texas. At the Institute for Cancer Research, work was undertaken with support primarily from Cancer Research UK. We are also grateful to the National Cancer Research Network, HEAL and Sanofi-Aventis. A. Matakidou was the recipient of a clinical research fellowship from the Allan J. Lerner Fund. We are also thankful for the unstinting efforts of the study coordinators and interviewers, including S. Honn, P. Porter, S. Ritter and J. Rogers. We also thank the study participants, who had the most critical role in this research.
Author information
Margaret R Spitz and Richard S Houlston: These authors contributed equally to this work.
Authors and Affiliations
Department of Epidemiology, The University of Texas M.D. Anderson Cancer Center, Houston, 77030, Texas, USA
Christopher I Amos, Xifeng Wu, Ivan P Gorlov, Jian Gu, Qiong Dong, Qing Zhang, Xiangjun Gu, Wei Vivien Chen, Sanjay Shete & Margaret R Spitz
Section of Cancer Genetics, Institute of Cancer Research, SM2 5NG, UK
Peter Broderick, Jayaram Vijayakrishnan, Kate Sullivan, Athena Matakidou, Yufei Wang & Richard S Houlston
Department of Oncology, University of Cambridge, Cambridge, CB2 2RE, UK
Timothy Eisen
Department of Systems Biology, University of Texas M.D. Anderson Cancer Center, Houston, 77030, Texas, USA
Gordon Mills
Center for Inherited Disease Research, Institute of Genetic Medicine, Johns Hopkins University School of Medicine, 333 Cassell Drive, Suite 2000, Baltimore, 21224, Maryland, USA
Kimberly Doheny & Ya-Yu Tsai
- Christopher I Amos
You can also search for this author inPubMed Google Scholar
- Xifeng Wu
You can also search for this author inPubMed Google Scholar
- Peter Broderick
You can also search for this author inPubMed Google Scholar
- Ivan P Gorlov
You can also search for this author inPubMed Google Scholar
- Jian Gu
You can also search for this author inPubMed Google Scholar
- Timothy Eisen
You can also search for this author inPubMed Google Scholar
- Qiong Dong
You can also search for this author inPubMed Google Scholar
- Qing Zhang
You can also search for this author inPubMed Google Scholar
- Xiangjun Gu
You can also search for this author inPubMed Google Scholar
- Jayaram Vijayakrishnan
You can also search for this author inPubMed Google Scholar
- Kate Sullivan
You can also search for this author inPubMed Google Scholar
- Athena Matakidou
You can also search for this author inPubMed Google Scholar
- Yufei Wang
You can also search for this author inPubMed Google Scholar
- Gordon Mills
You can also search for this author inPubMed Google Scholar
- Kimberly Doheny
You can also search for this author inPubMed Google Scholar
- Ya-Yu Tsai
You can also search for this author inPubMed Google Scholar
- Wei Vivien Chen
You can also search for this author inPubMed Google Scholar
- Sanjay Shete
You can also search for this author inPubMed Google Scholar
- Margaret R Spitz
You can also search for this author inPubMed Google Scholar
- Richard S Houlston
You can also search for this author inPubMed Google Scholar
Contributions
Texas: C.I.A. and M.R.S. conceived of this study. M.R.S. established the Texas lung cancer study. C.I.A. supervised and performed the analyses. G.M. provided oversight in manuscript development and in the conduct of genetic studies. I.P.G., Q.D., Q.Z., W.V.C. and X.G. performed statistical analyses. S.S. developed and implemented statistical procedures for joint analysis. X.W. and J.G. oversaw genotyping for Texas studies. ICR: R.S.H. and T.E. established GELCAPS. R.S.H. supervised laboratory analyses. A.M. oversaw GELCAPS and developed the database. P.B. supervised sample organization, genotyping and sequencing. Y.W. provided database management. K.S. and J.V. performed DNA preparation and sequencing. CIDR: K.D. and Y.-Y.T. were responsible for direction of GWA genotyping and genotype data quality assurance conducted by the Center for Inherited Disease Research. All authors contributed to the final paper, with C.I.A., R.S.H., M.R.S., I.P.G., K.D., S.S. and Y.-Y.T. playing key roles.
Corresponding author
Correspondence toChristopher I Amos.
Supplementary information
Supplementary Text and Figures
Supplementary Methods, Supplementary Figure 1, Supplementary Tables 1–7 (PDF 1109 kb)
Rights and permissions
About this article
Cite this article
Amos, C., Wu, X., Broderick, P.et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1.Nat Genet40, 616–622 (2008). https://doi.org/10.1038/ng.109
Received:
Accepted:
Published:
Issue Date:
This article is cited by
Association between smoking and alcohol drinking and benign adrenal tumors: a Mendelian randomization study
- Kun Peng
- Qingyuan Liu
- Degang Ding
Endocrine (2024)
Accurate and efficient estimation of local heritability using summary statistics and the linkage disequilibrium matrix
- Hui Li
- Rahul Mazumder
- Xihong Lin
Nature Communications (2023)
SNP+ to predict dropout rates in SNP arrays
- N. Sastre
- A. Mercadé
- J. Casellas
Conservation Genetics Resources (2023)
An analysis of genetically regulated gene expression and the role of co-expression networks across 16 psychiatric and substance use phenotypes
- Zachary F. Gerring
- Jackson G. Thorp
- Eske M. Derks
European Journal of Human Genetics (2022)
The α5-nAChR/PD-L1 axis facilitates lung adenocarcinoma cell migration and invasion
- Ping Zhu
- Guiyu Kang
- Xiaoli Ma
Human Cell (2022)